Literature DB >> 34070773

Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature Review.

Freya Wenzel1,2, Anne Pralong1,2, Udo Holtick2,3, Christoph Scheid2,3, Marco Herling2,3,4, Steffen T Simon1,2,5.   

Abstract

Graft-versus-host disease (GvHD) is a frequent, and often life-threatening, complication after an allogeneic, hematopoietic stem cell transplantation (allo-SCT). It can appear in an acute or a chronic form and presents different grades of severity. Particularly, the severe forms of GvHD are often responsible for a change of the curative intent for allo-SCT into a palliative goal of care. For this non-systematic review, we conducted a focused literature search in the MEDLINE database via PubMed to examine whether patients with severe forms of GvHD might have special needs and burdens from a supportive and palliative care perspective. To draw a comprehensive picture of this patient group, we included findings on quality of life (QoL) and physical symptoms and function as well as psychological and spiritual well-being. In most domains, patients with severe forms of GvHD showed greater impairment and a higher symptom burden compared to patients with milder forms of GvHD. However, we could not identify any studies that specifically investigated patients with severe forms of GvHD. Further research in this field is necessary to guarantee the highest standard of care for this very special patient group.

Entities:  

Keywords:  graft-versus-host disease; hematopoietic stem cell transplantation; palliative care; physical function; quality of life; supportive care

Year:  2021        PMID: 34070773     DOI: 10.3390/cancers13112697

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  56 in total

1.  The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.

Authors:  Daniel Wolff; Hartmut Bertz; Hildegard Greinix; Anita Lawitschka; Jörg Halter; Ernst Holler
Journal:  Dtsch Arztebl Int       Date:  2011-10-28       Impact factor: 5.594

2.  Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study.

Authors:  Z Kuzmina; S Eder; A Böhm; E Pernicka; L Vormittag; P Kalhs; V Petkov; G Stary; J Nepp; R Knobler; U Just; K Krenn; N Worel; H T Greinix
Journal:  Leukemia       Date:  2011-09-16       Impact factor: 11.528

3.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

4.  Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Authors:  Holly K Miller; Thomas M Braun; Terri Stillwell; Andrew C Harris; Sung Choi; James Connelly; Daniel Couriel; Steven Goldstein; Carrie L Kitko; John Magenau; Attaphol Pawarode; Pavan Reddy; Mary Riwes; Gregory A Yanik; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-22       Impact factor: 5.742

5.  Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.

Authors:  Joseph Pidala; Brenda F Kurland; Xiaoyu Chai; Georgia Vogelsang; Daniel J Weisdorf; Steven Pavletic; Corey Cutler; Navneet Majhail; Stephanie J Lee
Journal:  Haematologica       Date:  2011-06-17       Impact factor: 9.941

6.  Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.

Authors:  Brian A Harris; Ann M Berger; Sandra A Mitchell; Seth M Steinberg; Karen L Baker; Daniel L Handel; Jacques L Bolle; Eric G Bush; Daniele Avila; Steven Z Pavletic
Journal:  J Support Oncol       Date:  2010 May-Jun

Review 7.  Chronic graft-versus-host disease.

Authors:  Stephanie J Lee; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2003-04       Impact factor: 5.742

Review 8.  Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

Authors:  Daniel Couriel; Humberto Caldera; Richard Champlin; Krishna Komanduri
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

9.  Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation.

Authors:  Ryota Hamada; Tadakazu Kondo; Masanobu Murao; Jyunsuke Miyasaka; Michiko Yoshida; Manabu Nankaku; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda
Journal:  Support Care Cancer       Date:  2019-11-12       Impact factor: 3.603

10.  Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

Authors:  A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.